Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) went up by 3.39% from its latest closing price compared to the recent 1-year high of $21.86. The company’s stock price has collected 6.12% of gains in the last five trading sessions.
Is It Worth Investing in Vanda Pharmaceuticals Inc. (NASDAQ :VNDA) Right Now?
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) scored a price-to-earnings ratio above its average ratio, recording 31.37 x from its present earnings ratio. Plus, the 36-month beta value for VNDA is at 0.59.
VNDA currently public float of 54.46M and currently shorts hold a 7.71% ratio of that float. Today, the average trading volume of VNDA was 512.00K shares.
VNDA’s Market Performance
VNDA stocks went up by 6.12% for the week, with a monthly drop of -0.10% and a quarterly performance of -14.46%, while its annual performance rate touched -47.14%. The volatility ratio for the week stands at 3.45% while the volatility levels for the past 30 days are set at 3.96% for Vanda Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is 3.94% for VNDA stocks with a simple moving average of -27.48% for the last 200 days.
Analysts’ Opinion of VNDA
Many brokerage firms have already submitted their reports for VNDA stocks, with Jefferies repeating the rating for VNDA by listing it as a “Hold.” The predicted price for VNDA in the upcoming period, according to Jefferies is $12 based on the research report published on February 25th of the current year 2022.
BofA Securities, on the other hand, stated in their research note that they expect to see VNDA reach a price target of $22. The rating they have provided for VNDA stocks is “Buy” according to the report published on May 12th, 2021.
Citigroup gave a rating of “Neutral” to VNDA, setting the target price at $14 in the report published on January 14th of the previous year.
VNDA Trading at 0.30% from the 50-Day Moving Average
After a stumble in the market that brought VNDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.28% of loss for the given period.
Volatility was left at 3.96%, however, over the last 30 days, the volatility rate increased by 3.45%, as shares surge +2.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.33% lower at present.
During the last 5 trading sessions, VNDA rose by +5.88%, which changed the moving average for the period of 200-days by -40.26% in comparison to the 20-day moving average, which settled at $9.84. In addition, Vanda Pharmaceuticals Inc. saw -37.03% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at VNDA starting from Mitchell Stephen Ray, who sale 2,700 shares at the price of $9.48 back on Jun 13. After this action, Mitchell Stephen Ray now owns 6,515 shares of Vanda Pharmaceuticals Inc., valued at $25,593 using the latest closing price.
Watkins Thomas, the Director of Vanda Pharmaceuticals Inc., sale 6,441 shares at $9.90 during a trade that took place back on Jun 02, which means that Watkins Thomas is holding 63,064 shares at $63,779 based on the most recent closing price.
Stock Fundamentals for VNDA
Equity return is now at value 3.60, with 3.10 for asset returns.